» Articles » PMID: 32161666

Emergence of Norovirus Strains: A Tale of Two Genes

Overview
Journal Virus Evol
Date 2020 Mar 13
PMID 32161666
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Noroviruses are a very diverse group of viruses that infect different mammalian species. In humans, norovirus is a major cause of acute gastroenteritis. Multiple norovirus infections can occur in a lifetime as the result of limited duration of acquired immunity and cross-protection among different strains. A combination of advances in sequencing methods and improvements on surveillance has provided new insights into norovirus diversification and emergence. The generation of diverse norovirus strains has been associated with (1) point mutations on two different genes: ORF1, encoding the non-structural proteins, and ORF2, encoding the major capsid protein (VP1); and (2) recombination events that create chimeric viruses. While both mechanisms are exploited by all norovirus strains, individual genotypes utilize each mechanism differently to emerge and persist in the human population. GII.4 noroviruses (the most prevalent genotype in humans) present an accumulation of amino acid mutations on VP1 resulting in the chronological emergence of new variants. In contrast, non-GII.4 noroviruses present co-circulation of different variants over long periods with limited changes on their VP1. Notably, genetic diversity of non-GII.4 noroviruses is mostly related to the high number of recombinant strains detected in humans. While it is difficult to determine the precise mechanism of emergence of epidemic noroviruses, observations point to multiple factors that include host-virus interactions and changes on two regions of the genome (ORF1 and ORF2). Larger datasets of viral genomes are needed to facilitate comparison of epidemic strains and those circulating at low levels in the population. This will provide a better understanding of the mechanism of norovirus emergence and persistence.

Citing Articles

Multiple Co-Infecting Caliciviruses in Oral Fluid and Enteric Samples of Swine Detected by a Novel RT-qPCR Assay and a 3'RACE-PCR-NGS Method.

Laszlo Z, Pankovics P, Urban P, Herczeg R, Balka G, Igriczi B Viruses. 2025; 17(2).

PMID: 40006947 PMC: 11860220. DOI: 10.3390/v17020193.


Genomic characterization of noroviruses from an outbreak associated with oysters.

Flint A, Harlow J, McLeod M, Blondin-Brosseau M, Weedmark K, Nasheri N Microbiol Spectr. 2025; 13(2):e0258024.

PMID: 39792002 PMC: 11793256. DOI: 10.1128/spectrum.02580-24.


Detection of Porcine Norovirus GII.18 Strains in Pigs Using Broadly Reactive RT-qPCR Assay for Genogroup II Noroviruses.

Gupta A, Heinonen M, Konig E, Mikkonen V, Maunula L Food Environ Virol. 2024; 17(1):7.

PMID: 39738992 PMC: 11685272. DOI: 10.1007/s12560-024-09619-x.


Public surface disinfection every 2 hours can reduce the infection risk of norovirus in airports up to 83.

Zhang N, Zhuang L, King M, Qian H, Zhu M PLoS Comput Biol. 2024; 20(12):e1012561.

PMID: 39636806 PMC: 11620375. DOI: 10.1371/journal.pcbi.1012561.


Characterization of cross-reactive, non-neutralizing monoclonal antibodies against a pandemic GII.4 norovirus variant.

Ford-Siltz L, Tohma K, Kihn K, Kendra J, Deredge D, Wintrode P Microbiol Spectr. 2024; :e0114324.

PMID: 39470287 PMC: 11619288. DOI: 10.1128/spectrum.01143-24.


References
1.
Choi J, Hutson A, Estes M, Prasad B . Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A. 2008; 105(27):9175-80. PMC: 2453692. DOI: 10.1073/pnas.0803275105. View

2.
Atmar R, Bernstein D, Lyon G, Treanor J, Al-Ibrahim M, Graham D . Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol. 2015; 22(8):923-9. PMC: 4519714. DOI: 10.1128/CVI.00196-15. View

3.
Atmar R, Baehner F, Cramer J, Song E, Borkowski A, Mendelman P . Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial. J Infect Dis. 2016; 214(6):845-53. PMC: 6281356. DOI: 10.1093/infdis/jiw259. View

4.
Alvarado G, Ettayebi K, Atmar R, Bombardi R, Kose N, Estes M . Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Gastroenterology. 2018; 155(6):1898-1907. PMC: 6402321. DOI: 10.1053/j.gastro.2018.08.039. View

5.
Siebenga J, Vennema H, Renckens B, de Bruin E, van der Veer B, Siezen R . Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol. 2007; 81(18):9932-41. PMC: 2045401. DOI: 10.1128/JVI.00674-07. View